This site is an independent educational resource for research compounds. We do not sell, distribute, or endorse human consumption of any compound. By entering, you confirm you are 21 years of age or older and agree to our Terms & Privacy Policy.
Also known as: MOTS-c
MOTS-c is a mitochondrial-derived peptide (MDP) encoded within the mitochondrial genome's 12S rRNA region. Discovered in 2015 by researchers at USC, it represents a paradigm shift in understanding mitochondria as active endocrine signaling organelles.
MOTS-c translocates from mitochondria to the nucleus in response to metabolic stress, where it regulates gene expression programs related to antioxidant defense, glucose metabolism, and folate cycle activity. It activates AMPK, driving glucose uptake and fatty acid oxidation similar to exercise. In skeletal muscle, it enhances insulin sensitivity by improving glucose transporter (GLUT4) membrane translocation. Emerging evidence suggests it also modulates inflammatory cytokines and acts as a systemic metabolic regulator.
MOTS-c translocates from mitochondria to the nucleus in response to metabolic stress, where it regulates gene expression programs related to antioxidant defense, glucose metabolism, and folate cycle activity. It activates AMPK, driving glucose uptake and fatty acid oxidation similar to exercise. In skeletal muscle, it enhances insulin sensitivity by improving glucose transporter (GLUT4) membrane translocation. Emerging evidence suggests it also modulates inflammatory cytokines and acts as a systemic metabolic regulator.
MOTS-c is a mitochondrial-derived peptide (MDP) encoded within the mitochondrial genome's 12S rRNA region. Discovered in 2015 by researchers at USC, it represents a paradigm shift in understanding mitochondria as active endocrine signaling organelles. Research focuses on metabolic regulation, insulin sensitivity, exercise mimicry, and longevity, with plasma levels declining with age.
IUPAC Name
Mitochondrial open reading frame of 12S rRNA-c (MRFA-peptide)
CAS Number
1600863-63-5
Molecular Formula
C104H181N33O28S
Molecular Mass
2174.39 g/mol
Create a free account to:
Join 2,800+ researchers
Create a free account to:
Join 2,800+ researchers
Active cancer. Severe diabetes without monitoring. Pregnancy or breastfeeding.
Research Disclaimer
This interaction data is compiled from published research and community reports. It may not be exhaustive. Always consult a healthcare professional before combining compounds.
$44.99
up to $175.00
$4.3750
4
5
vial
163 PubMed studies
Data Completeness
100%COA Verification
10
Verified COAs
2
Vendors w/ COA
High verification rate (83%)
Latest test: 3/1/2026
Research Credibility
Well-researched compound
Half-Life
~4β6 hours
Molecular Weight
2174.39 g/mol
Administration
Subcutaneous, Intramuscular
CAS Number
1600863-63-5
Trial Phase
Preclinical
Common Side Effects
Stop Use If
Research Disclaimer
This information is for educational and research purposes only. Not intended as medical advice. Consult a healthcare professional before use.
MOTS-c is a mitochondrial-derived peptide (MDP) encoded within the mitochondrial genome's 12S rRNA region. Discovered in 2015 by researchers at USC, it represents a paradigm shift in understanding mitochondria as active endocrine signaling organelles. Research focuses on metabolic regulation, insulin sensitivity, exercise mimicry, and longevity, with plasma levels declining with age.
MOTS-c is available in vial form.
Prices start at $44.99 across 4 verified vendors.
Compare prices, payment methods, shipping, and COA scores across 4 vendors.